| Dr Charles Thomas Ivester, MD | |
|
5957 Fashion Point Dr Ste 103, South Ogden, UT 84403-5180 | |
| (385) 492-4930 | |
| (385) 492-4449 |
| Full Name | Dr Charles Thomas Ivester |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | 5957 Fashion Point Dr Ste 103, South Ogden, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376585372 | NPI | - | NPPES |
| 1376585372 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 349313-1205 (Utah) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 349313-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ogden Regional Medical Center | Ogden, UT | Hospital |
| Portneuf Medical Center | Pocatello, ID | Hospital |
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Eastern Idaho Regional Medical Center | Idaho falls, ID | Hospital |
| Mckay Dee Hospital | Ogden, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ogden Pulmonary Associates Pllc | 3678638517 | 8 |
| Idaho Falls Community Hospital Llc | 9032441597 | 9 |
| Ogden Pulmonary Associates Pllc | 3678638517 | 8 |
News Archive
Scientists have shown how alcohol damages DNA in stem cells, helping to explain why drinking increases your risk of cancer, according to research part-funded by Cancer Research UK and published in Nature today (Wednesday).
Over the past months, Republicans enjoyed enormous advantages. Opinion polls showed that voters are eager to reduce the federal debt, and they want to do it mostly but not entirely through spending cuts. There was a Democratic president eager to move to the center. He floated certain ideas that would be normally unheard of from a Democrat.
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.
The results of a study presented at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer.
› Verified 2 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Scientists have shown how alcohol damages DNA in stem cells, helping to explain why drinking increases your risk of cancer, according to research part-funded by Cancer Research UK and published in Nature today (Wednesday).
Over the past months, Republicans enjoyed enormous advantages. Opinion polls showed that voters are eager to reduce the federal debt, and they want to do it mostly but not entirely through spending cuts. There was a Democratic president eager to move to the center. He floated certain ideas that would be normally unheard of from a Democrat.
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.
The results of a study presented at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer.
› Verified 2 days ago
| Entity Name | Ogden Pulmonary Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457596801 PECOS PAC ID: 3678638517 Enrollment ID: O20090210000370 |
News Archive
Scientists have shown how alcohol damages DNA in stem cells, helping to explain why drinking increases your risk of cancer, according to research part-funded by Cancer Research UK and published in Nature today (Wednesday).
Over the past months, Republicans enjoyed enormous advantages. Opinion polls showed that voters are eager to reduce the federal debt, and they want to do it mostly but not entirely through spending cuts. There was a Democratic president eager to move to the center. He floated certain ideas that would be normally unheard of from a Democrat.
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.
The results of a study presented at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Thomas Ivester, MD Po Box 150627, Ogden, UT 84415-0627 Ph: (385) 492-4930 | Dr Charles Thomas Ivester, MD 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403-5180 Ph: (385) 492-4930 |
News Archive
Scientists have shown how alcohol damages DNA in stem cells, helping to explain why drinking increases your risk of cancer, according to research part-funded by Cancer Research UK and published in Nature today (Wednesday).
Over the past months, Republicans enjoyed enormous advantages. Opinion polls showed that voters are eager to reduce the federal debt, and they want to do it mostly but not entirely through spending cuts. There was a Democratic president eager to move to the center. He floated certain ideas that would be normally unheard of from a Democrat.
Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.
The results of a study presented at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer.
› Verified 2 days ago
Wojciech C Janowski, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Robert Cheney, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 801-807-7597 | |
Christopher K Anderson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Mohammad Omer Syed, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Dr. Gaurav Dagar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 | |
Terrence Wayne Andrews, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5957 Fashion Point Dr Ste 103, South Ogden, UT 84403 Phone: 385-492-4930 Fax: 385-492-4449 |